Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Targeted Abdominal Perfusion Pressure Reduce Renal Injury and Mortality in Septic Shock Patients? A Prospective Controlled Trial

NCT05358912 is registered in ClinicalTrials.gov with Bozyaka Training and Research Hospital as lead sponsor.

NCT NCT05358912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05358912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Targeted Abdominal Perfusion Pressure Reduce Renal Injury and Mortality in Septic Shock Patients? A Prospective Controlled Trial
Lead sponsor
Bozyaka Training and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 2, 2019
Completion date
September 21, 2022
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraabdominal hypertension, renal injury, septic shock, septicemia